Interestingly, in osteosarcoma 143B cells depleted of SLC1A5, Broer et al. observed compensation by SLC38A1 and SLC38A2 for glutamine transport, but not in triple-negative breast cancer HCC1806 cells [53]. This evidence concerns the gene SLC1A5 and triple-negative breast carcinoma.